Pharma Journalist -

After successful completion of pre-clinical safety studies for MIV-818 which is Medivir AB’s liver targeted nucleotide prodrug for diagnosing hepatocellular carcinoma and other forms of…
Read More...

Clinical-stage Immunology Company asserted appointment of Sterna Biologicals as the Chief Executive Officer who has over 25 years of experience in life science specifically in areas of…
Read More...

Acercus pharmaceuticals declare exclusive distributor and license agreement with Innovus Pharmaceuticals. UriVarx is a Natural Health Product (NHP) that alleviates symptoms of…
Read More...

On having received $ 38 million Series A financing by Maxim Merchant Capital, Alveo technologies to embark on curation of efficient and cost-effective disease diagnostic devices aiding…
Read More...

Shanghai Sinobioway Sunterra Biotechnology (SSSB) and F1 oncology initiate new development, manufacturing, and supply to finish a new cGMP manufacturing facility in Shenzhen with the…
Read More...

Takeda Pharmaceuticals and Denali therapeutics asserted that they have collaborated to develop and commercialize up to three specified therapeutic product candidates for…
Read More...

Celgene and Impact biomedicines signed an agreement that enumerates acquisition of Impact Biomedicines by Celgene to develop fedratinib for myelofibrosis and Polycythemia Vera. As per…
Read More...

A generic pharmaceutical company Leading Pharma, LLC that manufactures and distributes drug chains, wholesalers declared that it became a successful recipient of $ 40 million of growth…
Read More...

Semnur Pharmaceuticals announced the commencement of phase 3 clinical trials in the U.S to evaluate its product SP-102 in patients suffering from lumbar radicular pain/sciatica. It is…
Read More...

Biopharmaceutical company Kala pharmaceuticals into development and commercialization of product candidates incorporating the usage of MPP technology declared that the New drug…
Read More...